Combination drug treatment prolongs survival of experimentally infected mice with silver-haired bat rabies virus.

Combination drug treatment prolongs survival of experimentally infected mice with silver-haired bat rabies virus.
复制标题

DOI:
10.1016/j.vaccine.2018.05.065
复制
发表时间:
2019-08
期刊:
影响因子:
5.5
通讯作者:
B. Martina;M. Smreczak;A. Orłowska;A. Marzec;P. Trębas;Jouke M. Roose;J. Żmudziński;I. Gerhauser;P. Wohlsein;W. Baumgärtner;A. Osterhaus;P. Koraka
B. Martina;M. Smreczak;A. Orłowska;A. Marzec;P. Trębas;Jouke M. Roose;J. Żmudziński;I. Gerhauser;P. Wohlsein;W. Baumgärtner;A. Osterhaus;P. Koraka
中科院分区:
医学3区
文献类型:
--
作者:
B. Martina;M. Smreczak;A. Orłowska;A. Marzec;P. Trębas;Jouke M. Roose;J. Żmudziński;I. Gerhauser;P. Wohlsein;W. Baumgärtner;A. Osterhaus;P. Koraka

文献摘要

相似文献

狂犬病是人类和动物的致命疾病,每年造成约6万人死亡。目前,除了暴露后预防(PEP)之外,没有可用的治疗方法,只要发生与狂犬病动物的接触,就可以进行这种治疗。在这里,我们描述了在感染后第4天开始的组合治疗的有益效果,包含抗病毒药物和免疫调节剂在感染小鼠中。联合治疗可显著延长存活时间(P < 0.05),并显著降低脑和脊髓中的病毒RNA(P < 0.05)。此外,治疗影响了通过TNF-α水平测量的焦亡和细胞凋亡以及早期炎症反应的标志物。狂犬病病毒感染的小鼠没有形态学病变,几乎没有炎症迹象。然而,这些在不同的组之间并不显著。
Rabies is a lethal disease in humans and animals, killing approximately 60,000 people every year. Currently, there is no treatment available, except post-exposure prophylaxis (PEP) that can be administered whenever exposure to a rabid animal took place. Here we describe the beneficial effects of a combination treatment initiated at day 4 post infection, containing anti-viral drugs and immune modulators in infected mice. Combination therapy resulted in significant increase in survival time (P < 0.05) and significantly lowers viral RNA in the brain and spinal cord (P < 0.05). Furthermore, treatment influenced markers of pyroptosis and apoptosis and early inflammatory response as measured by the levels of TNF-α. Morphological lesions were absent in rabies virus infected mice with few signs of inflammation. However, these were not significant between the different groups.